June 20, 2018
Article
An Extraordinary Healer essay honoring KATIE PARKER, B.S.N., RN, CPN, CHPPN [ST. JUDE CHILDREN’S RESEARCH HOSPITAL, MEMPHIS, TENNESSEE]
FDA Approves Inlexzo for Some With Non–Muscle Invasive Bladder Cancer
Lunsumio plus Polivy Associated With Responses in MCL
Standing Up to Cancer with Lynch Syndrome
Zidesamtinib Elicits Responses in ROS1-Positive NSCLC